Fernando E. Membreno

985 citations
15 papers · 742 · 1 hit paper · h-index 8

Impact in

  • Hepatology top 1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 9
    • Liver Disease and Transplantation 2
    • Liver Diseases and Immunity 1
    • Hepatitis B Virus Studies 5
    • Liver Disease Diagnosis and Treatment 4
    • Herpesvirus Infections and Treatments 2

Fernando E. Membreno

14 papers receiving 713 citations

Fernando E. Membreno's Hit Papers

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial 2013 · 449 citations
4490+4+8Years since publication100200300400

Peers

Fernando E. Membreno
Comparison fields: 5 of 50
  • Hepatology 623
  • Epidemiology 418
  • Infectious Diseases 81
  • Virology 10
  • Transplantation 5
Replace Ewa Janczewska with:
Ewa Janczewska Poland
Edward Tam Canada
Etsuko Iio Japan
Kenneth Hirsch United States
Lai My Taiwan
D. Hueppe Germany
R. Soffredini Italy
Akihiro Nasu Japan
V. Carreño Spain
Hiromitsu Kumada Japan
Fernando E. Membreno relative to Ewa Janczewska Poland Ewa Janczewska's profile →
Citations per field
00.5×1.5×1.9×
Ewa Janczewska · 1×
Citations per year

Countries citing papers authored by Fernando E. Membreno

Since Specialization
Citations

This map shows the geographic impact of Fernando E. Membreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando E. Membreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando E. Membreno more than expected).

Fields of papers citing papers by Fernando E. Membreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando E. Membreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando E. Membreno. The network helps show where Fernando E. Membreno may publish in the future.

Co-authors

The 25 scholars most cited alongside Fernando E. Membreno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando E. Membreno Line = papers co-authored together Fernando E. Membreno links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Hit paper breakdown →
2013449
2 201491
3 202367
4 201143
5 200532
6 201221
7 201412
8 200811
9 20046
10 20053
11 20122
12 20032
13 20202
14 20081
15 20200

About Fernando E. Membreno

Fernando E. Membreno is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Surgery and Molecular Biology, having authored 15 papers that have together received 742 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (2 papers), Herpesvirus Infections and Treatments (2 papers), Liver Diseases and Immunity (1 paper), Silk-based biomaterials and applications (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Hepatology (623 citations), Epidemiology (418 citations), Infectious Diseases (81 citations), Virology (10 citations) and Transplantation (5 citations). Fernando E. Membreno has collaborated with scholars based in United States, Hong Kong and Australia. Frequent co-authors include Eric Lawitz, William T. Symonds, Fred Poordad, Robert H. Hyland, John G. McHutchison, Phillip S. Pang, Hongmei Mo, Xiao Ding, Diana M. Brainard and Di An. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Hepatology, Clinics in Liver Disease, Transplantation and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact